Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology. | Int J Mol Sci | 2023 | 37373074 | PubTator, text mining | PubMed |
| Current Therapies for Cholestatic Diseases. | Biomedicines | 2023 | 37371808 | PubTator, text mining | PubMed |
| Pre- and Post-Transcriptional Control of HBV Gene Expression: The Road Traveled towards the New Paradigm of HBx, Its Isoforms, and Their Diverse Functions. | Biomedicines | 2023 | 37371770 | PubTator, text mining | PubMed |
| Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes. | Liver Int | 2023 | 37366005 | PubTator, text mining | PubMed |
| Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification. | Front Pharmacol | 2023 | 37361218 | PubTator, text mining | PubMed |
| Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. | Acta Pharm Sin B | 2023 | 37360014 | PubTator, text mining | PubMed |
| An efficient strategy to select head and neck cancer patients for adaptive radiotherapy. | Radiother Oncol | 2023 | 37353058 | PubTator, text mining | PubMed |
| Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion. | Cardiovasc Diabetol | 2023 | 37349757 | PubTator, text mining | PubMed |
| Diagnosis and Management of Hepatitis Delta Virus Infection. | Dig Dis Sci | 2023 | 37338616 | PubTator, text mining | PubMed |
| SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression. | J Virol | 2023 | 37338350 | PubTator, text mining | PubMed |
| Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation for analyzing extracellular viral markers. | bioRxiv | 2023 | 37333409 | PubTator, text mining | PubMed |
| A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes. | Sci Rep | 2023 | 37328616 | PubTator, text mining | PubMed |
| Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. | Nat Commun | 2023 | 37328459 | PubTator, text mining | PubMed |
| Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? | Front Immunol | 2023 | 37325634 | PubTator, text mining | PubMed |
| Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview. | Front Pharmacol | 2023 | 37324475 | PubTator, text mining | PubMed |
| Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. | Front Pharmacol | 2023 | 37324459 | PubTator, text mining | PubMed |
| Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression. | Microorganisms | 2023 | 37317092 | PubTator, text mining | PubMed |
| Clinical isolates of hepatitis B virus genotype C have higher in vitro transmission efficiency than genotype B isolates. | J Med Virol | 2023 | 37314050 | PubTator, text mining | PubMed |
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial. | BMC Cancer | 2023 | 37312053 | PubTator, text mining | PubMed |
| Current and novel modalities for management of chronic hepatitis B infection. | World J Hepatol | 2023 | 37305370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=20